This week, Hims & Hers’ (NYSE:HIMS) recent Super Bowl ad campaign was at least twice mentioned by Marty Makary, Commissioner of the U.S. Food and Drug Administration (FDA) as a glaring example of how ...
For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs — including popular weight loss medications — as part of the ...
The advertisement failed to adequately disclose the drugs' potential side effects, violating rules that require prescription medication ads to present a balanced view of benefits and risks, Reuters ...
WASHINGTON (AP) — For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs — including popular weight loss medications — ...
WASHINGTON — For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs — including popular weight loss medications — as ...
Hims & Hers Health's ads have been getting attention from the Trump administration. President Donald Trump's administration on Tuesday rolled out a memorandum aimed at limiting direct-to-consumer ...
Hims & Hers shares plunged earlier this week after Novo Nordisk ended its collaboration with the company. The stock appears to be bouncing back as it nears oversold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results